Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03875573 |
| Title | Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: (Neo-CheckRay) |
| Acronym | Neo-CheckRay |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Jules Bordet Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Institut Jules Bordet | Brussels | 1000 | Belgium | Details | ||
| Cliniques Universitaires Saint-Luc | Brussels | 1200 | Belgium | Details | ||
| Universitaire Ziekenhuizen | Leuven | 3000 | Belgium | Details | ||
| CHU UCL Namur Sainte-Elisabeth | Namur | 5000 | Belgium | Details | ||
| GZA - Ziekenhuizen (Campus St. Augustinus) | Wilrijk | 2610 | Belgium | Details | ||
| Centre Georges François Leclerc | Dijon | 21079 | France | Details | ||
| Institut Curie | Paris | 75248 | France | Details |